Orna Therapeutics
A Research Associate in Analytical Development CMC for a contract role at Orna Therapeutics, focusing on characterization of circular RNA and nanoparticle products through analytical testing and bioassay development.
Headquarters
Watertown, Massachusetts, United States
Company Size
51-200 employees
Founded
2019
Orna Therapeutics is a biotechnology company creating fully engineered circular RNA (oRNA) therapeutics — an entirely new class of RNA medicines. The company designs and optimizes circular RNA molecules to enable durable, high‑level protein expression for applications such as vaccines, protein replacement, and cell therapies. Orna operates a platform-driven, engineering-first approach aimed at improving RNA stability, manufacturability, and translational potential to advance next‑generation medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orna Therapeutics.
13% above the average for this role
Advisor, Analytical Sciences
Eli Lilly and Company
Senior Scientist I, Analytical Development, Biologics CMC
Exelixis
Senior Scientist, Analytical Development
Bristol Myers Squibb
Research Associate / Senior Research Associate (Contract)
Addition Therapeutics
Technical Development
Moderna
Senior Principal Scientist
Eli Lilly and Company